Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
3
×
biotech
boston blog main
boston top stories
clinical trials
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
10x genomics
abbvie
alder biopharmaceuticals
alirocumab
allergan
alnylam pharmaceuticals
anemia
antibiotic
What
fda
3
×
drug
medicines
new
won
acquire
agreed
amgen
approval
august
billion
bio
biotech
brings
busy
candidates
cash
cholesterol
class
company
compound
days
deal
decisions
developed
devices
drugs
gets
head
legacy
medco
migraine
news
nod
nods
novartis
opioid
pain
past
poised
Language
unset
Current search:
novartis
×
fda
×
amgen
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
